COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,479 Articles (22,358 medRxiv, 8,121 bioRxiv)

Most recent first Previous |  Page 83: Articles 821-830  | Next

RSV healthcare burden in adults before and since the emergence of the COVID-19 pandemic in 6 European countries
Osei-Yeboah, R., Urchueguia-Fornes, A., Jollivet, O., Johannesen, C. K., Lehtonen, T., van Boven, M., Gideonse, D., Cohen, R. A., Orrico-Sanchez, A., Kramer, R., Fischer, T. K., Heikkinen, T., Nair, H., Campbell, H.
10.1101/2024.09.20.24314093 — Posted: 2024-09-24
Harnessing multi-output machine learning approach and dynamical observables from network structure to optimize COVID-19 intervention strategies
Alves, C., Kuhnert, K., Rodrigues, F. A., Moeckel, M.
10.1101/2024.09.23.24313636 — Posted: 2024-09-24
Personal protective beliefs and behaviors during the COVID-19 pandemic at a large, multi-campus, public university in Pennsylvania: a cross-sectional survey
Long, B. A., Stachowski, J., Kuruppumullage Don, P., Murphy, R. P., Pomerantz, L. D.
10.1101/2024.09.23.24314227 — Posted: 2024-09-24
SARS-CoV-2, the human placenta, and adverse perinatal outcomes
Linn, R. L., Forkpa, M., Leite, R., Guerrero, J. C., Reyes, M. C., Schwartz, L. E., Simmons, R. A., Parry, S., Golden, T. N.
10.1101/2024.09.20.24313999 — Posted: 2024-09-23
Application and Significance of SIRVB Model in Analyzing COVID-19 Dynamics
Ariyaratne, P., Ramasinghe, L. P., Ayyash, J. S., Kelley, T. M., Plant-Collins, T. A., Shinkle, L. W., Zuercher, A. M., Chen, J.
10.1101/2024.09.21.24314129 — Posted: 2024-09-23
Postpartum Depression During the COVID-19 Pandemic and Associated Factors: A Cross-Sectional Study
Teruya, M. M., Carrijo, G. S., Costa, G. A. M., Da Silva, M. H., Lima, J. R. T. d., Costa, J. F. S. V., Strufaldi, R., Valete, C. O. S.
10.1101/2024.09.22.24314126 — Posted: 2024-09-23
Preventive interventions for post Covid-19 condition: systematic review update
Pillay, J., Rahman, S., Gehring, N., Guitard, S., Ashiq, A. R., Hartling, L.
10.1101/2024.09.18.24313918 — Posted: 2024-09-23
Emergence to dominance: Estimating time to dominance of SARS-CoV-2 variants using nonlinear statistical models
Awasthi, S., Zolfaghari Dehkharghani, M., Fudolig, M.
10.1101/2024.09.21.24314137 — Posted: 2024-09-23
Accurate Multiple Sequence Alignment of Ultramassive Genome Sets
Lai, X., Luan, H., Tian, P.
10.1101/2024.09.22.613454 — Posted: 2024-09-23
Neuroinvasive and neurovirulent potential of SARS-CoV-2 in the acute and post-acute phase of intranasally inoculated ferrets
Benavides, F. F. W., Kroeze, E. J. B. V., Leijten, L. M., Schmitz, K. S., van Run, P., Kuiken, T., de Vries, R. D., Bauer, L., van Riel, D.
10.1101/2024.09.21.614276 — Posted: 2024-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).